BMS-284640 is a potent and selective inhibitor of sodium-hydrogen exchanger isoform-1 (NHE-1), with over 380-fold higher inhibitory activity against NHE-1 (IC50: 9 nM) compared to cariporide (HY-19693), and demonstrates improved selectivity over NHE-2 (IC50: 1.8 μM) and NHE-5 (IC50: 3.36 μM); it also exhibits enhanced oral bioavailability and prolonged plasma half-life in rats.